https://doi.org/10.1038/s41586-020-2732-8
E
Emily Graham
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
18
Papers
3.0K
Citations
11
h-index
11
i10-index
Emily Graham is an academic researcher from Roche (United Kingdom). The author has contributed to research in topics: COVID-19 Clinical Research Studies & Ferroptosis and cancer prognosis & Long-Term Effects of COVID-19. The author has an h-index of 11, co-authored 16 publications.
ORCID: 0000-0001-6696-4564Papers by this author
worksPlasticity of ether lipids promotes ferroptosis susceptibility and evasion
2020 · Nature · 787 citations
Cytochrome P450 oxidoreductase contributes tophospholipid peroxidation in ferroptosis
2020 · Nature Chemical Biology · 672 citations
https://doi.org/10.1038/s41589-020-0472-6
Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA)
2022 · EClinicalMedicine · 37 citations
https://doi.org/10.1016/j.eclinm.2022.101409
Efficacy of Baloxavir Treatment in Preventing Transmission of Influenza
2025 · New England Journal of Medicine · 25 citations
https://doi.org/10.1056/nejmoa2413156
Design and rationale of the COVID vaccine-associated myocarditis/pericarditis (CAMP) study
2024 · American Heart Journal · 1 citations
https://doi.org/10.1016/j.ahj.2024.11.008
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat